SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-015824
Filing Date
2024-04-11
Accepted
2024-04-11 16:21:35
Documents
10
Period of Report
2024-04-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A esperion-definitive2023pro.htm DEF 14A 967072
2 blookersigv2a.jpg GRAPHIC 5422
3 capnetlossv2a.jpg GRAPHIC 181390
4 captsrv2a.jpg GRAPHIC 179185
5 espe_rmxrgbxfcxpos002a.jpg GRAPHIC 44145
6 proxycard11a.jpg GRAPHIC 104965
7 proxycard12a.jpg GRAPHIC 159703
8 proxycard21a.jpg GRAPHIC 107580
9 proxycard22a.jpg GRAPHIC 85086
10 sheldonsignaturea.jpg GRAPHIC 20271
  Complete submission text file 0001628280-24-015824.txt   2186740
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35986 | Film No.: 24838778
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)